| Staphylococcus aureus |
prevention of colonisation on medical foreign bodies (in vivo model of implant infection) |
(Materazzi et al. 2020) |
| virulence |
(Andrade et al. 2022; Golla et al. 2021; Gomez et al. 2022; Mishra et al. 2021; Oyama et al. 2022; Rao et al. 2022; Wang et al. 2021; Zheng et al. 2021) |
| testing an antibacterial hydrogel containing the peptide (Naphthalene-2-ly)-acetyl-diphenylalanine-dilysine-OH (NapFFKK-OH) |
(McCloskey et al. 2019) |
| in vivo antimicrobial activity |
(Chagas Almeida et al. 2019) |
| in vivo efficacy of cefazolin and fosfomycin in the treatment of MRSA infections |
(Kussmann et al. 2021) |
| in vivo efficacy of phage preparations: staphylococcal bacteriophage (containing monophage Sb-1) and bacteriophage mixture (PYO) |
(Tkhiaishvili et al. 2020) |
| infection model associated with biofilm on stainless steel and titanium implants |
(Mannala et al. 2021) |
| biofilm formation inside the larvae |
(Campos-Silva et al. 2019) |
| resistance to infection |
(Sheehan et al. 2021) |
| regulation of humoral immunity by photodynamic therapy (PDT) |
(Huang et al. 2020) |
| maximum tolerated dose (MTD) of PPT, NNC, TBB, GW4064 and PD198306 |
(Khader et al. 2020) |
| toxicity of CM3a (5-maleimide-substituted chromone compounds) |
(Qing et al. 2021) |
| evaluation of the activity of bacteriophage 191219 against biofilm on metal implants with and without antibiotics |
(Mannala et al. 2022) |
| antimicrobial activity of diethyldithiocarbamate and copper ions |
(Kaul et al. 202) |
| Streptomyces griseocarneus |
production of compounds with antimicrobial activity |
(de Siqueira et al. 2021) |
| Staphylococcus pseudintermedius |
virulence |
(Andrade et al. 2022) |
| Staphylococcus coagulans |
virulence |
(Andrade et al. 2022) |
| Staphylococcus epidermidis |
testing of an antibacterial hydrogel containing a peptide (Naphthalene-2-ly)-acetyl-diphenylalanine-dilysine-OH (NapFFKK-OH) |
(McCloskey et al. 2019) |
| antimicrobial activity of diethyldithiocarbamate and copper ions |
(Kaul et al. 2022) |
| Escherichia coli |
testing of an antibacterial hydrogel containing a peptide (Naphthalene-2-ly)-acetyl-diphenylalanine-dilysine-OH (NapFFKK-OH) |
(McCloskey et al. 2019) |
| virulence |
(Antoine et al. 2021; Duan et al. 2020; Wojda et al. 2020) |
| in vivo antimicrobial efficacy of lactoferricin |
(Vergis et al. 2020) |
| in vivo antimicrobial efficacy of indolicidin |
(Vergis et al. 2019) |
| microRNA expression (miRNA) |
(Mukherjee et al. 2020) |
| photodynamic therapy activity (PDT) |
(Garcez et al. 2023) |
| antimicrobial activity of the combination of PMB and LL-37 |
(Ridyard et al. 2023) |
| Pseudomonas aeruginosa |
testing of an antibacterial hydrogel containing a peptide (Naphthalene-2-ly)-acetyl-diphenylalanine-dilysine-OH (NapFFKK-OH) |
(Piatek et al. 2021) |
| virulence |
(Alonso et al. 2020; Calcagnile et al. 2023; Fraser-Pitt et al. 2021) |
| antimicrobial activity of silver nanoparticles against UCBPP-PA14 strain |
(Thomaz et al. 2020) |
| antimicrobial activity of pyokines S5 and AP41 |
(Six et al. 2021) |
| antimicrobial activity of the combination of PMB and LL-37 |
(Ridyard et al. 2023) |
| Bacillus cereus |
iron homeostasis |
(Consentino et al. 2021) |
